Clinical Trial Update: A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study [Phase 4]

View source ↗

Summary

The STEAL trial evaluated safety and efficacy after switching HIV patients to either tenofovir-emtricitabine or abacavir-lamivudine in an open-label Phase 4 stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 4 | Status: COMPLETED